Abstract
Background: A reduction in key antioxidants such as glutathione has been noted in brain tissue undergoing oxidative stress in aging and neurodegeneration. To date, no dietary factor has been linked to a higher glutathione concentration. However, in an earlier pilot study, we showed evidence of a positive association between cerebral glutathione and dairy intake.
Objective: We tested the hypothesis that dairy food consumption is associated with cerebral glutathione concentrations in older adults.
Design: In this observational study, we measured cerebral glutathione concentrations in 60 healthy subjects (mean ± SD age: 68.7 ± 6.2 y) whose routine dairy intakes varied. Glutathione concentrations were measured by using a unique, noninvasive magnetic resonance chemical shift imaging technique at 3 T and compared with dairy intakes reported in 7-d food records.
Results: Glutathione concentrations in the frontal [Spearman's rank-order correlation (rs) = 0.39, P = 0.013], parietal (rs = 0.50, P = 0.001), and frontoparietal regions (rs = 0.47, P = 0.003) were correlated with average daily dairy servings. In particular, glutathione concentrations in all 3 regions were positively correlated with milk servings (P ≤ 0.013), and those in the parietal region were also correlated with cheese servings (P = 0.015) and calcium intake (P = 0.039). Dairy intake was related to sex, fat-free mass, and daily intakes of energy, protein, and carbohydrates. However, when these factors were controlled through a partial correlation, correlations between glutathione concentrations and dairy and milk servings remained significant.
Conclusions: Higher cerebral glutathione concentrations were associated with greater dairy consumption in older adults. One possible explanation for this association is that dairy foods may serve as a good source of substrates for glutathione synthesis in the human brain.
Keywords: aging brain, dairy foods, dietary intake, glutathione, magnetic resonance spectroscopy
See corresponding editorial on page 249
INTRODUCTION
The term “oxidative stress” refers to an imbalance between the production of reactive oxygen species (ROS)4 and their neutralization by antioxidant defenses (1, 2). The brain is particularly vulnerable to oxidative stress because of its high level of oxidative metabolism, relatively low concentrations of cytosolic antioxidants, and high concentrations of transition metal ions and metals (e.g., iron) as well as PUFAs (3, 4). The intracellular production of ROS is greatly elevated in many neurodegenerative diseases in conjunction with inflammation and mitochondrial dysfunction (5–7). Accordingly, oxidative stress has been implicated in normal aging and many neurodegenerative diseases.
Glutathione is a powerful antioxidant that plays a key role in the brain's capacity for scavenging ROS and free radicals involved in oxidative stress. Protection against oxidative stress is directly afforded through the oxidation of glutathione in mitochondria (8, 9), and decreased concentrations of glutathione were reported in the aging rat brain (10–12). A significantly elevated ROS generation and cellular stress because of mitochondrial dysfunction and inflammation commonly accompany neurodegenerative disorders, and the resulting burden on the brain's antioxidant defenses would likewise be reflected by reductions in concentrations of glutathione (13–15). However, the measurement of glutathione in living tissue is technically challenging, particularly in the human brain, and until recently, the level of oxidative stress could be evaluated only indirectly by using in vitro measures obtained from blood, cerebrospinal fluid, or biopsy tissue samples. By contrast, the work reported here was based on our successful application of magnetic resonance (MR) chemical shift imaging (CSI) to provide regional mapping of in vivo glutathione concentrations in the living human brain (16–18).
Dietary factors may influence the antioxidant capacity of the brain because dietary supplementation was reported to modulate enzyme activities of antioxidants in animal brains (19, 20). Therefore, in one of our early exploratory studies of glutathione in the human brain, we collected data from a food-frequency questionnaire that pertained to the usual dietary intake in a small sample of healthy older adults. The results indicated a positive association between glutathione and the consumption of dairy foods (unpublished data). However, because of the small sample size and large number of correlations examined in the exploratory study, a replication and elaboration on the nature of this relation was warranted. The current study was designed in accordance with these aims by using more-extensive procedures for measuring dietary intake and focusing specifically on the principal dairy foods themselves (milk, cheese, and yogurt) and nutrients obtained in large measure through dairy consumption (e.g., calcium, vitamin D, and riboflavin).
SUBJECTS AND METHODS
Subjects
Between December 2011 and February 2014, we enrolled 60 healthy adults whose ages ranged from 60 to 85 y and who resided in the greater Kansas City metro area in an observational study aimed at investigating the association between dairy food intake and brain glutathione concentrations. The study protocol was approved by the Human Subjects Committee at the University of Kansas Medical Center. Our exclusion criteria included individuals with a history of neurologic disorders, a head injury, claustrophobia, diabetes, unstable medical conditions, malabsortive syndromes such as gluten and lactose intolerance, or the use of dietary supplements that might alter glutathione concentration such as glutathione or N-acetylcysteine. Informed consent was obtained from all study participants. To ensure a broad distribution of dairy intake, we recruited subjects in the following 3 groups on the basis of their initially reported daily intakes of dairy as follows: low (<1 serving/d), moderate (1–2 servings/d), and recommended (≥3 servings/d).
Dietary intake assessment
During subject screening, dietary intake was assessed by using 3 standardized, multiple-pass 24-h dietary recalls. These recalls were unannounced and conducted via telephone by trained diet-assessment staff. The information was entered into the Nutrition Data System for Research (NDSR; version 2012), which is commonly used to collect dietary recalls and analyze data from dietary recalls and food records (21) for nutrient- and food-grouping analysis. The resulting data were used to classify subjects initially into the 3 recruitment groups on the basis of their 3-d average intakes of dairy foods (milk, cheese, and yogurt).
To assess dietary intake before the MR scan, 7-d diet records were obtained from all subjects. These records also included all dietary supplements taken by the subject. To facilitate the compiling of these records, subjects were given verbal and written directions on how to accurately record their dietary intakes. Subjects were instructed to stop taking calcium supplements for the 7 d before the scan. On the day of the scan, 7-d diet records were reviewed by a registered dietitian and entered into the NDSR for a nutrient- and food-grouping analysis. The 7-d diet recording period before the MR scan was chosen to provide sufficient time to capture any dietary intake that might influence glutathione concentrations on the basis of the turnover time of glutathione in the brain. Because of its slower turnover rate compared with that of other metabolites (e.g., aspartate, glutamate, and glutamine), it takes ∼3 d for the complete turnover of glutathione pools in the rat brain (22). The turnover period was likely to be longer in the human brain on the basis of the general relation between metabolic rates to body mass in mammals (23).
To determine whether there was any difference in the general diet quality in the 3 recruitment groups on the basis of dairy consumption, Healthy Eating Index (HEI)–2010 scores were calculated from 7-d diet records. The HEI-2010 is a measure of diet quality developed by the USDA that assesses conformance to the 2010 Dietary Guidelines for Americans (24). Components considered for daily intake included total fruit, whole fruit, total vegetables, dark green vegetables and beans, refined grains, whole grains, milk, meat and beans, seafood and plant protein, the fatty acid ratio, sodium, and empty calories. Point values on the basis of how well a person met dietary guidelines for each component were calculated by entering the NDSR output into a custom algorithm (25). The sum of these point values was totaled to yield the final HEI score for each day expressed as a percentage per 1000 kcal with 100 points as the maximum score.
Anthropometric measures
Body weight, height, and waist circumference were measured for all subjects before their MR scans. Body weight was measured with a calibrated digital scale (±0.1 kg; Befour). Height was measured with a wall-mounted stadiometer (model PE-WM-60–84; Perspective Enterprises). Waist circumference was measured in the standing position with measurements obtained midway between the lateral lower rib margin and ileac crest (26). BMI (in kg/m2) was calculated by using weight and height measurements. Body composition was measured by using a bioelectrical impedance analyzer (Quantum IV; RJL Systems) with the participant in the reclined position. Fat and fat-free muscle mass were determined by using the NHANES III equation set for general populations (27).
MR protocol
All MR scans were performed on a 3-T system (Skyra; Siemens). After positioning the participant supine in the magnet, 3-plane scout MR images were acquired to locate the volume of interest, a 3-cm axial slab positioned above the corpus callosum and also located in the iso-center of the magnet. In vivo mapping of glutathione was performed with a multiple quantum-filtered, CSI technique that used a 2-echo scheme (18, 28, 29). Spectral data of glutathione and creatine were processed with software written in-house in Interactive Data Language 6.3 (RSI) as described previously (17). In brief, glutathione and creatine spectra were first processed with 2 Hz line broadening, and glutathione doublet signals were fitted with 2 Lorentzian peaks separated by 4 Hz at ∼2.9 ppm. Singlet signals of creatine at 3.03 ppm and choline at 3.21 ppm were fitted by a Lorentzian peak at each respective signal position. Spectral fitting was performed by using the Levenberg-Marquardt algorithm implemented in the MPFIT curve-fitting package (Craig Markwardt, http://www.physics.wisc.edu/~craigm/idl/fitting.html). Concentrations of glutathione were determined by using an internal reference method, which employed the creatine signals acquired simultaneously with those of glutathione taking into account the relaxation times, volume definition, and editing efficiency. The use of creatine as an internal concentration reference provided an automatic correction for brain atrophy (17, 28, 29).
Glutathione concentrations were calculated from the central region (5 × 5 × 3 cm3) of CSI data, where the static magnetic field (B0) was the most adjusted for the conservative estimation of glutathione. The total area spanned portions of both frontal and parietal lobes and was labeled frontoparietal. In addition, glutathione concentrations were measured from the anterior one-half (2.5 × 5 cm2) and the posterior one-half (2.5 × 5 cm2) and labeled mostly frontal and mostly parietal, respectively (17). Glutathione concentrations from all 3 areas were obtained independently from each specified area, and the glutathione concentration from the frontoparietal area was not merely the arithmetic average of the 2 regional values from the mostly frontal and mostly parietal areas.
Statistical analysis
On the basis of our earlier exploratory study, the primary focus of the current study was to investigate the relation between glutathione concentrations and daily consumption of dairy foods. The reason for recruiting subjects from 3 dairy-consumption groups (low, moderate, or recommended intakes) was to ensure diversity in dairy consumption across the sample. From the outset, the intention was to treat dairy consumption as a continuous variable rather than structuring the data analysis around the 3 groups. Therefore, primary analyses consisted of bivariate correlations between glutathione concentrations and dairy consumption.
This more-informed focus of the study also dictated the other variables included in secondary analyses. Most of these variables were selected on the basis of their possible utility for illuminating the relation between dairy consumption and glutathione and, therefore, consisted of the principal dairy foods themselves (milk, cheese, and yogurt) and nutrients obtained largely through dairy consumption such as calcium, vitamin D, and riboflavin. Other variables were selected to complete each subject's overall dietary profile in terms of the major nutritional components (carbohydrates, protein, and fat). Finally, the 3 specific nutrients vitamin C, vitamin E, and selenium were examined because they are known to have major antioxidant properties.
Distributions of all variables were tested for normality by using the Kolmogorov-Smirnov test. Glutathione concentrations in all 3 areas (frontal, parietal, and frontoparietal) were distributed normally. However, many of the dietary variables including daily servings of dairy were positively skewed to a significant degree. Therefore, the bivariate relations reported throughout this article are nonparametric correlations on the basis of Spearman's rank-order coefficients. Because of the large number of dietary variables (i.e., 14) examined in this study, P values for all analyses involving these variables were adjusted by using the false-discovery rate (30) to correct for the expanded possibility of a type 1 error resulting from multiple comparisons.
RESULTS
A total of 60 participants (21 men and 39 women) who ranged in age from 60 to 83 y (mean ± SD: 68.7 ± 6.2 y) completed the study. The initial classification into 3 recruitment groups was reassessed on the basis of subjects’ 7-d diet records. The final classification was changed for 17 of 60 subjects. Of the participants, 12 subjects were changed to a lower category (recommended to moderate: n = 7; moderate to low: n = 5), and 5 subjects were changed to a higher category (low to moderate: n = 3; moderate to recommended: n = 2). Anthropometric and dietary intake characteristics of the sample are listed in Table 1.
TABLE 1.
Anthropometric and dietary characteristics for the overall sample and each dairy-consumption group1
| Overall (n = 60) |
Dairy-consumption groups |
|||||
| Value | Range | Low (n = 21) | Moderate (n = 24) | Recommended (n = 15) | P | |
| Age, y | 68.7 ± 6.22 | 60–83 | 69.3 ± 6.4 | 67.0 ± 5.7 | 70.5 ± 6.4 | 0.190 |
| Education, y | 17.3 ± 2.7 | 12–29 | 17.4 ± 3.8 | 17.1 ± 2.1 | 17.6 ± 1.8 | 0.857 |
| HEI3 | 62.5 ± 11.3 | 34–89 | 61.2 ± 11.0 | 61.7 ± 10.2 | 65.5 ± 13.5 | 0.490 |
| BMI, kg/m2 | 25.4 ± 4.2 | 17–36 | 24.9 ± 4.5 | 26.3 ± 3.5 | 24.5 ± 4.62 | 0.327 |
| Fat mass4 | 22.5 ± 7.5 | 8–47 | 22.1 ± 7.3 | 24.1 ± 8.3 | 20.5 ± 6.3 | 0.329 |
| Fat-free mass4 | 51.3 ± 13.0 | 29–79 | 48.1 ± 13.9 | 50.2 ± 10.7 | 57.5 ± 13.9 | 0.087 |
| Dietary intake5 | ||||||
| Energy, kcal | 1788 ± 457 | 791–3172 | 1637 ± 369 | 1719 ± 445 | 2108 ± 455 | 0.014 |
| Protein, g | 75.6 ± 21.1 | 27–133 | 69.4 ± 18.8 | 70.9 ± 19.1 | 91.7 ± 19.9 | 0.006 |
| Carbohydrate, g | 217.2 ± 74.5 | 99–481 | 188.9 ± 62.3 | 211.5 ± 80.9 | 266.2 ± 56.9 | 0.016 |
| Fat, g | 67.9 ± 21.7 | 17–139 | 65.0 ± 18.8 | 65.4 ± 21.2 | 76.2 ± 25.5 | 0.328 |
| Fruit, servings/d | 2.28 ± 1.93 | 0.2–10.6 | 2.19 ± 1.77 | 2.38 ± 2.43 | 2.26 ± 1.21 | 0.951 |
| Vegetables, servings/d | 3.41 ± 1.68 | 0.7–9.7 | 3.53 ± 2.11 | 3.43 ± 1.28 | 3.21 ± 1.65 | 0.910 |
| Grains, servings/d | 5.41 ± 2.41 | 1.8–16.5 | 4.99 ± 1.97 | 5.22 ± 2.81 | 6.31 ± 2.17 | 0.328 |
| Meats and beans, servings/d | 5.28 ± 2.57 | 0.3–11.8 | 6.47 ± 2.24 | 4.42 ± 1.95 | 5.01 ± 3.31 | 0.072 |
| Dairy, servings/d | 1.83 ± 1.37 | 0.0–4.6 | 0.44 ± 0.30 | 1.85 ± 0.59 | 3.74 ± 0.61 | <0.001 |
| Milk, servings/d | 1.08 ± 1.15 | 0.0–3.8 | 0.09 ± 0.11 | 0.94 ± 0.63 | 2.70 ± 0.75 | <0.001 |
| Cheese, servings/d | 0.56 ± 0.49 | 0.0–2.3 | 0.26 ± 0.22 | 0.70 ± 0.60 | 0.77 ± 0.38 | 0.004 |
| Yogurt, servings/d | 0.19 ± 0.21 | 0.0–0.9 | 0.09 ± 0.11 | 0.21 ± 0.21 | 0.29 ± 0.27 | 0.058 |
| Calcium, mg | 1090 ± 501 | 308–2662 | 752 ± 352 | 999 ± 276 | 1708 ± 401 | <0.001 |
| Riboflavin, mg | 5.3 ± 12.1 | 1.0–87.8 | 5.9 ± 18.8 | 5.9 ± 8.1 | 3.6 ± 1.0 | 0.910 |
| Vitamin C, mg | 300 ± 794 | 21–6062 | 208 ± 231 | 435 ± 1218 | 217 ± 301 | 0.635 |
| Vitamin D, μg | 24.1 ± 28.1 | 1.3–135.9 | 27.4 ± 38.2 | 20.2 ± 21.4 | 25.7 ± 21.0 | 0.800 |
| Vitamin E, mg | 31.7 ± 51.4 | 2.2–214.7 | 56.7 ± 72.8 | 19.3 ± 34.7 | 16.4 ± 12.2 | 0.042 |
| Selenium, μg | 106.8 ± 40.1 | 33–278 | 106.6 ± 38.2 | 97.5 ± 36.2 | 122.1 ± 49.0 | 0.309 |
Final dairy-consumption groups on the basis of 7-d diet records. P values were based on a 1-factor ANOVA comparing the 3 dairy-consumption groups. P values for dietary intake variables were adjusted for multiple comparisons on the basis of the false-discovery rate (30).
Mean ± SD (all such values).
HEI, Healthy Eating Index.
On the basis of bioelectrical impedance.
On the basis of a 7-d diet record (per day).
Subjects in the final classification of low, moderate, and recommended dairy-consumption groups did not differ significantly in age, years of education, BMI, or overall quality of their diets as measured by using the HEI-2010 (Table 1). However, subjects in the recommended dairy group showed significantly higher energy, protein, and carbohydrate intakes than did the other groups. Also, there was a greater percentage of women in the recommended dairy group (60%) than low group (24%) or middle group (26%; chi-square = 6.1, df = 2, P = 0.046).
Glutathione CSI data were acquired from a slab spanning both frontal and parietal regions of the human brain shown as the rectangular volume of interest on T1-weighted sagittal and coronal MR images (Figure 1A). Figure 1B shows the mapping of glutathione CSI signals (Figure 1B, left) and simultaneously acquired creatine (Figure 1B, right), and both CSI spectra were overlaid on the anatomical MR images in the middle section of the CSI slab. Glutathione signals from protons of cysteine β-CH2 near 3 ppm were clearly visible in all CSI voxels. Consistent line shapes of glutathione and creatine signals showed a good quality of CSI data, which enabled a reliable quantification of glutathione concentrations. Table 2 presents glutathione concentrations in the frontal, parietal, and frontoparietal areas of the brain for each dairy-consumption group.
FIGURE 1.
GSH CSI and Cr CSI data overlaid on MRI. Location of the GSH CSI slab overlaid on T1-weighted sagittal and coronal MRI of the brain of a subject (A). The CSI slab (rectangles) was positioned superior to the corpus callosum in the frontoparietal regions of the brain. Partial views of GSH CSI (left) and simultaneously acquired Cr CSI (right) of a subject overlaid on T1-weighed transverse MRI corresponding to the middle slice of the CSI slab (B). Data-acquisition variables were slice thickness of 3 cm, matrix size of 8 × 8, nominal voxel size after one-time zero padding of 1.25 × 1.25 × 3 cm3, field of view of 20 cm, TE of 115 ms, TR of 1500 ms, and scan time of 16 min. Spectra of GSH CSI and Cr CSI were processed with 2-Hz line broadening. Cho, choline; Cr, creatine; CSI, chemical shift imaging; GSH, glutathione; NAA, N-acetylaspartate; TE, echo time; TR, repetition time.
TABLE 2.
Glutathione concentrations overall and for each dairy-consumption group1
| Overall (n = 60) |
Dairy-consumption groups |
|||||
| Brain regions for glutathione | Value | Range | Low (n = 21) | Moderate (n = 24) | Recommended (n = 15) | P |
| Frontal | 1.27 ± 0.322 | 0.43–1.92 | 1.09 ± 0.30 | 1.30 ± 0.32 | 1.42 ± 0.22 | 0.006 |
| Parietal | 1.28 ± 0.27 | 0.66–1.94 | 1.14 ± 0.23 | 1.31 ± 0.27 | 1.45 ± 0.22 | 0.002 |
| Frontoparietal | 1.29 ± 0.28 | 0.53–1.93 | 1.14 ± 0.24 | 1.30 ± 0.29 | 1.43 ± 0.22 | 0.004 |
Final dairy-consumption groups on the basis of 7-d diet records. P values were based on 1-factor ANOVA comparing the 3 dairy-consumption groups.
Mean ± SD (all such values).
Spearman's rank-order correlations (rs) were computed between each of the dietary variables and glutathione concentrations. As shown in Table 3, variables that reflected subjects’ general dietary intakes (i.e., energy, protein, carbohydrates, and fat) or their intakes of antioxidants (i.e., vitamin C, vitamin E, and selenium) obtained through diet and supplements were not associated with glutathione concentrations. Significant correlations with glutathione were confined to daily servings of dairy foods or the daily intake of calcium. Servings of dairy and milk were positively related to glutathione concentrations in all 3 brain areas, and daily intake of calcium was positively correlated with parietal and frontoparietal glutathione.
TABLE 3.
Relations between cerebral glutathione concentrations and dietary intake1
| Frontal glutathione |
Parietal glutathione |
Frontoparietal glutathione |
||||
| rs | P | rs | P | rs | P | |
| Energy,2 kcal | −0.057 | 0.795 | −0.028 | 0.921 | −0.011 | 0.936 |
| Protein,2 g | 0.054 | 0.795 | 0.079 | 0.813 | 0.093 | 0.821 |
| Carbohydrate,2 g | 0.001 | 0.994 | −0.043 | 0.921 | −0.012 | 0.936 |
| Fat,2 g | −0.197 | 0.370 | −0.101 | 0.813 | −0.083 | 0.821 |
| Dairy, servings/d | 0.394 | 0.013 | 0.500 | 0.001 | 0.465 | 0.003 |
| Milk, servings/d | 0.402 | 0.013 | 0.437 | 0.003 | 0.437 | 0.003 |
| Cheese, servings/d | 0.165 | 0.483 | 0.374 | 0.015 | 0.275 | 0.098 |
| Yogurt, servings/d | 0.006 | 0.994 | 0.024 | 0.921 | −0.025 | 0.936 |
| Calcium,2 mg/d | 0.280 | 0.145 | 0.328 | 0.039 | 0.328 | 0.047 |
| Riboflavin,2 mg/d | 0.245 | 0.207 | 0.230 | 0.216 | 0.273 | 0.098 |
| Vitamin C,2 mg/d | 0.072 | 0.795 | 0.096 | 0.813 | 0.040 | 0.936 |
| Vitamin D,2 μg/d | 0.135 | 0.534 | 0.187 | 0.355 | 0.177 | 0.408 |
| Vitamin E,2 mg/d | −0.147 | 0.524 | −0.013 | 0.921 | −0.047 | 0.936 |
| Selenium,2 μg/d | 0.081 | 0.795 | 0.073 | 0.813 | 0.106 | 0.821 |
Spearman's rank-order correlations with P values adjusted for multiple comparisons on the basis of the false-discovery rate (30).
Total daily intake from food and supplements.
Daily servings of dairy and milk showed the strongest associations with glutathione concentrations (Figure 2) with correlation coefficients that ranged between 0.394 and 0.500 (all P ≤ 0.013; Table 3). Neither dairy nor milk servings were related to age, BMI, fat mass, fat intake, or total scores on the HEI. However, both dairy and milk servings were positively related to intakes of fat-free mass (dairy: rs = 0.326, P = 0.011; milk: rs = 0.360, P = 0.005), energy (dairy: rs = 0.342, P = 0.007; milk: rs = 0.394, P = 0.002), protein (dairy: rs = 0.401, P = 0.002; milk: rs = 0.403, P = 0.001), and carbohydrate (dairy: rs = 0.375, P = 0.003; milk: rs = 0.458, P < 0.001). Also, women consumed more servings of dairy (t = 2.313, P = 0.024) and milk (t = 2.202, P = 0.032) than did men. Therefore, partial correlations were calculated to determine whether relations between glutathione and dairy or milk servings might be accounted for by these other variables. Even after controlling for fat-free mass, energy, protein, carbohydrates and sex, partial correlations (rp) between glutathione and dairy servings (frontal: rp = 0.385, P = 0.004; parietal: rp = 0.509, P < 0.001; frontoparietal: rp = 0.427, P = 0.001) or milk servings (frontal: rp = 0.399, P = 0.003; parietal: rp = 0.498, P < 0.001; frontoparietal: rp = 0.446, P = 0.001) remained significant.
FIGURE 2.
Correlations between dairy servings and GSH concentrations in the parietal region. The GSH concentration in the mostly parietal region showed a significant correlation with dairy servings per day (r = 0.50, P = 0.001, n = 60). Values of daily dairy servings were based on 7-d diet records obtained from each subject immediately before GSH measurement. The line indicates the best fit of data. Each data point represents a subject. GSH, glutathione.
DISCUSSION
The most-robust associations with brain glutathione concentrations in this sample of healthy older adults involved daily servings of dairy and milk. Furthermore, all other significant relations with brain glutathione concentrations involved nutrients that were largely obtained through dairy, particularly calcium. The consumption of dairy differed by sex and was positively related to fat-free mass and energy, protein, and carbohydrate intakes, but partial correlation analyses revealed that, collectively, these variables did not account for relations between glutathione and servings of either dairy or milk. These results confirmed the findings of our earlier exploratory study (data not shown). They were also consistent with the results of a recent study that used the Dietary Approaches to Stop Hypertension diet, which is rich in dairy food. Individuals randomly assigned to consume the Dietary Approaches to Stop Hypertension (DASH) diet were shown to have higher plasma glutathione concentrations (31).
The mechanism by which dairy may influence glutathione concentrations in the brain or elsewhere has yet to be determined; however, several possibilities were suggested in the literature. Dairy is a significant source of both calcium and riboflavin, both of which have been implicated in the maintenance of glutathione. The relation between calcium and glutathione has been investigated extensively, and studies indicated that cells depleted of calcium have reduced concentrations of glutathione (32, 33). The importance of riboflavin likely derives from the fact that the enzymatic activity of glutathione reductase requires riboflavin. Studies of riboflavin-deficient animals have reported lower glutathione concentrations in the liver (34) and eye lenses (35). The only comparable human study failed to find significant differences in erythrocyte glutathione concentrations in blood samples of 28 individuals classified into either riboflavin-adequate or -deficient subgroups (36). Nevertheless, a subsequent study reported an increase in glutathione reductase activity after riboflavin supplementation in women who were marginally deficient in this vitamin. In the current study, correlations between riboflavin and cerebral glutathione concentrations were positive (ranging between 0.230 and 0.273) but were NS.
Dairy foods are also rich in cysteine, which is a semiessential amino acid, that serves as the rate-limiting substrate for glutathione synthesis (37). Particularly, the whey protein fraction of milk is plentiful in cysteine, and several studies in animals (38–41) and humans (42–45) involving supplementation with whey protein or whey protein isolates have documented increases in plasma and tissue glutathione concentrations along with reductions in oxidative stress. For example, Zavorsky et al. (45) reported a dose response in lymphocyte glutathione concentrations in healthy young adults who consumed bars that contained increasing amounts of whey protein. A study of older adults with recent incidences of ischemic stroke reported increases in serum glutathione concentrations in those who consumed a whey-based formula, but no changes in those who consumed a casein-based formula (42). However, to our knowledge, the effect of these supplementations on the human brain has not been previously shown.
Lower concentrations of glutathione in plasma, erythrocytes, lymphocytes and gastric mucosa have been observed in older compared with younger adults (46–51). It has commonly been thought that both lower rates of glutathione synthesis and higher levels of oxidative stress in older adults were responsible for these differences. However, Sekhar et al. (52) concluded that lower glutathione in the elderly was attributable to inadequate precursors rather than diminished enzyme efficiency on the basis of their finding that no differences in glutathione were observed between older and younger subjects when the older group received cysteine and glycine supplementation. This finding raises the possibility that participants in the current study who were consuming less than recommended daily servings of dairy may have lacked sufficient precursor amino acids to support the adequate synthesis of glutathione. In line with this possibility, note that subjects in the recommended dairy-consumption group had significantly higher protein intake than in the other groups. In contrast, glutathione concentrations were not correlated with protein intake (Table 3), and analyses that used partial correlation did not support the notion that protein intakes accounted for the relation between dairy and glutathione. Because of the crucial role played by cysteine in the synthesis of glutathione, it would be interesting to examine the relation of both dairy servings and glutathione concentrations to cysteine. Unfortunately, different cysteine intakes are not provided through the NDSR database and, therefore, were unavailable for consideration in this study. An additional investigation is required to determine whether cysteine might serve as a vital nutrient linking dairy and brain glutathione concentrations.
In addition to the absence of data concerning dietary intakes of cysteine, another limitation of the current study was that all dietary intake data were based on self-reported methods, which are known to result in the underreporting of some dietary components (e.g., energy consumption) and overreporting of others (e.g., fruit and vegetables). It is also possible that the overreporting of dairy consumption resulted from transparency regarding the study's focus because recruitment clearly centered on the dairy consumption of individuals. However, note that energy and macronutrient intakes as well as HEI-2010 scores for this sample concurred with national data by the NHANES 2009–2010 (http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm) and the HEI reference (25).
The recruitment of older adults who met the recommendation for adequate dairy consumption consisting of ≥3 servings/d proved to be a difficult task. Our experience was consistent with the findings of national surveys in which only 23% of older adults in the United States appeared to meet dietary recommendations for dairy (53). Therefore, previous studies that reported lower concentrations of glutathione in peripheral samples obtained from older adults may have been influenced by low dairy intake. Future studies are needed to confirm that the consumption of dairy at recommended intakes improves brain glutathione concentrations in aging. If this effect is confirmed, obstacles to obtaining adequate dairy consumption in older adults should be examined and approaches toward circumventing such obstacles explored.
In conclusion, in this study the in vivo measurement of glutathione in the brains of older adults was achieved through MR spectroscopy by using a selective multiple quantum-filtered CSI technique developed in our laboratory. Brain glutathione concentrations were significantly related to adults’ reported consumption of dairy foods and calcium, which was obtained in large measure through dairy consumption. Research capitalizing on this approach for evaluating the effect of diet on brain antioxidants could lead to the development of new recommendations toward strengthening cerebral antioxidant defenses and, thereby, improving brain health in the aging population.
Acknowledgments
We thank E Sherry for assistance with data processing.
The authors’ responsibilities were as follows—I-YC, PL, and DKS: designed the research; I-YC, PL, KS, ON, AKR, and JAL: performed the research; LP: calculated the Healthy Eating Index 2010 scores; I-YC, PL, and DRD: analyzed data; PL and DRD: performed the statistical analysis; and I-YC, PL, DRD, and DKS: wrote the manuscript. None of the authors declared a potential conflict of interest. Funding organizations had no influence on the study design, implementation, analysis, or interpretation of data.
Footnotes
Abbreviations used: CSI, chemical shift imaging; HEI, Healthy Eating Index; MR, magnetic resonance; NDSR, Nutrition Data System for Research; ROS, reactive oxygen species.
REFERENCES
- 1.Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91(Suppl 3):31S–8S. [DOI] [PubMed] [Google Scholar]
- 2.Benzi G, Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 1995;16:661–74. [DOI] [PubMed] [Google Scholar]
- 3.Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, Morillas JM. Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chem 2006;13:1075–83. [DOI] [PubMed] [Google Scholar]
- 4.Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res 1999;24:321–9. [DOI] [PubMed] [Google Scholar]
- 5.Sayre LM, Moreira PI, Smith MA, Perry G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 2005;41:143–64. [PubMed] [Google Scholar]
- 6.Mancuso C, Scapagini G, Curro D, Giuffrida Stella AM, De Marco C, Butterfield DA, Calabrese V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci 2007;12:1107–23. [DOI] [PubMed]
- 7.Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010;345:91–104. [DOI] [PubMed] [Google Scholar]
- 8.de la Asuncion JG, Millan A, Pla R, Bruseghini L, Esteras A, Pallardo FV, Sastre J, Vina J. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 1996;10:333–8. [DOI] [PubMed] [Google Scholar]
- 9.Sastre J, Pallardo FV, Vina J. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 2000;49:427–35. [DOI] [PubMed] [Google Scholar]
- 10.Benzi G, Pastoris O, Marzatico F, Villa RF. Cerebral enzyme antioxidant system. Influence of aging and phosphatidylcholine. J Cereb Blood Flow Metab 1989;9:373–80. [DOI] [PubMed] [Google Scholar]
- 11.Geremia E, Baratta D, Zafarana S, Giordano R, Pinizzotto MR, La Rosa MG, Garozzo A. Antioxidant enzymatic systems in neuronal and glial cell-enriched fractions of rat brain during aging. Neurochem Res 1990;15:719–23. [DOI] [PubMed] [Google Scholar]
- 12.Rao G, Xia E, Richardson A. Effect of age on the expression of antioxidant enzymes in male Fischer F344 rats. Mech Ageing Dev 1990;53:49–60. [DOI] [PubMed] [Google Scholar]
- 13.Bains JS, Shaw CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 1997;25:335–58. [DOI] [PubMed] [Google Scholar]
- 14.Ferreira B, Mendes F, Osorio N, Caseiro A, Gabriel A, Valado A. Glutathione in multiple sclerosis. Br J Biomed Sci 2013;70:75–9. [DOI] [PubMed] [Google Scholar]
- 15.Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000;267:4904–11. [DOI] [PubMed] [Google Scholar]
- 16.Choi I-Y. Regional distribution of glutathione in the human brain in vivo. J Neurochem 2003;87(Suppl 1):161. [Google Scholar]
- 17.Choi I-Y, Lee S-P, Denney DR, Lynch SG. Lower levels of glutathione (GSH) in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler 2011;17:289–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Choi IY, Lee P. Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo. NMR Biomed 2013;26:28–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.O'Donnell E, Lynch MA. Dietary antioxidant supplementation reverses age-related neuronal changes. Neurobiol Aging 1998;19:461–7. [DOI] [PubMed] [Google Scholar]
- 20.Tchantchou F, Graves M, Ortiz D, Rogers E, Shea TB. Dietary supplementation with apple juice concentrate alleviates the compensatory increase in glutathione synthase transcription and activity that accompanies dietary- and genetically-induced oxidative stress. J Nutr Health Aging 2004;8:492–6. [PubMed] [Google Scholar]
- 21.Miller PE, Mitchell DC, Harala PL, Pettit JM, Smiciklas-Wright H, Hartman TJ. Development and evaluation of a method for calculating the Healthy Eating Index-2005 using the Nutrition Data System for Research. Public Health Nutr 2011;14:306–13. [DOI] [PubMed] [Google Scholar]
- 22.Choi I-Y, Gruetter R. Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo. J Neurochem 2004;91:778–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hulbert AJ, Else PL. Basal metabolic rate: history, composition, regulation, and usefulness. Physiological and biochemical zoology. Physiol Biochem Zool 2004;77:869–76. [DOI] [PubMed] [Google Scholar]
- 24.Guenther PM, Kirkpatrick SI, Reedy J, Krebs-Smith SM, Buckman DW, Dodd KW, Casavale KO, Carroll RJ. The Healthy Eating Index-2010 is a valid and reliable measure of diet quality according to the 2010 Dietary Guidelines for Americans. J Nutr 2014;144:399–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Guenther PM, Casavale KO, Reedy J, Kirkpatrick SI, Hiza HA, Kuczynski KJ, Kahle LL, Krebs-Smith SM. Update of the Healthy Eating Index: HEI-2010. J Acad Nutr Diet 2013;113:569–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988. [Google Scholar]
- 27.Chumlea WC, Guo SS, Kuczmarski RJ, Flegal KM, Johnson CL, Heymsfield SB, Lukaski HC, Friedl K, Hubbard VS. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord 2002;26:1596–609. [DOI] [PubMed]
- 28.Choi I-Y, Lee S-P, Merkle H, Shen J. Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo. Magn Reson Med 2004;51:1115–21. [DOI] [PubMed] [Google Scholar]
- 29.Choi I-Y, Lee S-P, Merkle H, Shen J. In vivo detection of gray and white matter differences in GABA concentration in the human brain. Neuroimage 2006;33:85–93. [DOI] [PubMed] [Google Scholar]
- 30.Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc, B 1995;57:289–300. [Google Scholar]
- 31.Asemi Z, Tabassi Z, Samimi M, Fahiminejad T, Esmaillzadeh A. Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial. Br J Nutr 2013;109:2024–30. [DOI] [PubMed] [Google Scholar]
- 32.Pascoe GA, Reed DJ. Cell calcium, vitamin E, and the thiol redox system in cytotoxicity. Free Radic Biol Med 1989;6:209–24. [DOI] [PubMed] [Google Scholar]
- 33.Reed DJ, Pascoe GA, Thomas CE. Extracellular calcium effects on cell viability and thiol homeostasis. Environ Health Perspect 1990;84:113–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Taniguchi M, Hara T. Effects of riboflavin and selenium deficiencies on glutathione and its relating enzyme activities with respect to lipid peroxide content of rat livers. J Nutr Sci Vitaminol (Tokyo) 1983;29:283–92. [DOI] [PubMed] [Google Scholar]
- 35.Dutta P, Rivlin RS, Pinto J. Enhanced depletion of lens reduced glutathione Adriamycin in riboflavin-deficient rats. Biochem Pharmacol 1990;40:1111–5. [DOI] [PubMed] [Google Scholar]
- 36.Powers HJ, Thurnham DI. Riboflavin deficiency in man: effects on haemoglobin and reduced glutathione in erythrocytes of different ages. Br J Nutr 1981;46:257–66. [DOI] [PubMed] [Google Scholar]
- 37.Lu SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 1999;13:1169–83. [PubMed] [Google Scholar]
- 38.Balbis E, Patriarca S, Furfaro AL, Millanta S, Sukkar SG, Marinari UM, Pronzato MA, Cottalasso D, Traverso N. Whey proteins influence hepatic glutathione after CCl4 intoxication. Toxicol Ind Health 2009;25:325–8. [DOI] [PubMed] [Google Scholar]
- 39.Bounous G, Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypotheses 1999;53:347–9. [DOI] [PubMed] [Google Scholar]
- 40.Kloek J, Mortaz E, Van Ark I, Bloksma N, Garssen J, Nijkamp FP, Folkerts G. A whey-based glutathione-enhancing diet decreases allergen-induced airway contraction in a guinea-pig model of asthma. Br J Nutr 2011;105:1465–70. [DOI] [PubMed] [Google Scholar]
- 41.Oner OZ, Ogunc AV, Cingi A, Uyar SB, Yalcin AS, Aktan AO. Whey feeding suppresses the measurement of oxidative stress in experimental burn injury. Surg Today 2006;36:376–81. [DOI] [PubMed] [Google Scholar]
- 42.de Aguilar-Nascimento JE, Prado Silveira BR, Dock-Nascimento DB. Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition 2011;27:440–4. [DOI] [PubMed] [Google Scholar]
- 43.Grey V, Mohammed SR, Smountas AA, Bahlool R, Lands LC. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003;2:195–8. [DOI] [PubMed] [Google Scholar]
- 44.Middleton N, Jelen P, Bell G. Whole blood and mononuclear cell glutathione response to dietary whey protein supplementation in sedentary and trained male human subjects. Int J Food Sci Nutr 2004;55:131–41. [DOI] [PubMed] [Google Scholar]
- 45.Zavorsky GS, Kubow S, Grey V, Riverin V, Lands LC. An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. Int J Food Sci Nutr 2007;58:429–36. [DOI] [PubMed] [Google Scholar]
- 46.Al-Turk WA, Stohs SJ, el-Rashidy FH, Othman S. Changes in glutathione and its metabolizing enzymes in human erythrocytes and lymphocytes with age. J Pharm Pharmacol 1987;39:13–6. [DOI] [PubMed] [Google Scholar]
- 47.Erden-Inal M, Sunal E, Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem Funct 2002;20:61–6. [DOI] [PubMed] [Google Scholar]
- 48.Lang CA, Naryshkin S, Schneider DL, Mills BJ, Lindeman RD. Low blood glutathione levels in healthy aging adults. J Lab Clin Med 1992;120:720–5. [PubMed] [Google Scholar]
- 49.Loguercio C, Taranto D, Vitale LM, Beneduce F, Del Vecchio Blanco C. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Radic Biol Med 1996;20:483–8. [DOI] [PubMed] [Google Scholar]
- 50.Matsubara LS, Machado PE. Age-related changes of glutathione content, glutathione reductase and glutathione peroxidase activity of human erythrocytes. Braz J Med Biol Res 1991;24:449–54. [PubMed] [Google Scholar]
- 51.Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P, Jr., Reed RL, Jones DP. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998;24:699–704. [DOI] [PubMed] [Google Scholar]
- 52.Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, Jahoor F. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr 2011;94:847–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ervin RB. Healthy Eating Index scores among adults, 60 years of age and over, by sociodemographic and health characteristics: United States, 1999-2002. Adv Data 2008;395:1–16. [PubMed] [Google Scholar]


